Add Yahoo as a preferred source to see more of our stories on Google. When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems like an ...

There is no cure for the common cold, but medications can help ease symptoms so you can relax and recover. To find the best ...

You’re standing in a store aisle looking at a shelf that’s as packed with cold remedies as your throat is filled with phlegm. It hurts. Your sinuses are stuffed and you have a cough that comes and ...

Here’s what you can use instead. By Dani Blum See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega ...

CVS is voluntarily removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday. The company's decision ...

For those who have suspected that a given cold medicine was not actually having any effects on the mucus-saturated misery of their chest, sinuses, and general head area, there’s some validating news ...

You've got the sniffles, and your nose is running like a faucet. The tissues feel like sandpaper. Many Australians reach for ...

A decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, say government experts who reviewed the latest research on the long-questioned ...

They found that cold and flu-like symptoms associated with COVID-19 could be relieved by OTC medicines, and that it is reasonable for these medicines to be licensed by the regulatory authorities to ...

Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. Phenylephrine is both ...

The cost of health insurance is expected to rise by the largest amount in years. WSJ reporter Anna Wilde Mathews joins host J.R. Whalen to discuss why costs are rising, and who’ll pay more.